The drug has been granted Breakthrough Therapy designation by the FDA for the treatment of chronic hepatitis delta (CHD).

A U.S. study reveals a 4.5% prevalence of post-COVID-19 ME/CFS, shedding light on the link between SARS-CoV-2 infection and ...

Discover the latest evidence on optimal stopping ages for colorectal cancer screening based on age, sex, comorbidity, and ...

Discover how poor sleep quality significantly increases malnutrition risk in adolescents with cystic fibrosis. Learn why ...

Study suggests extending colonoscopy rescreening beyond 10 years for low-risk individuals based on long-term colorectal ...

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) develops significantly more frequently following SARS-CoV-2 ...

A new meta-analysis has provided further insight into the effects of time-restricted eating combined with exercise on body ...

Shanghai-based Junshi Biosciences has announced a partnership with Denmark’s LEO Pharma to distribute and commercialise the ...

Better donor-recipient heart size matching with echocardiographic LVM improves post-transplant survival, especially in ...

Discover a recent study, the RAIDER trial, in which 82% of patients received dose-escalated radiotherapy and experienced ...

Study identifies NMLR as a predictor of 5-year mortality in COPD patients, paving the way for personalised care and improved survival outcomes.

The research focused on 101 acute ischaemic stroke patients. “We quantified the myelin volume in patients with acute ...